GlassScriptPhysician profile
Lucy Cuevas Loya
NPI 1609916600
$1,887.96
in general payments reported to CMS, 2019-2025
20 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $353 · 2022: $605 · 2023: $281 · 2024: $301 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $454.19 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $322.73 | 2021-2025 | Mounjaro |
| Merck Sharp & Dohme LLC | $212.26 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Bayer Healthcare Pharmaceuticals INC. | $206.72 | 2022-2024 | |
| Pfizer INC. | $157.25 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $140.25 | 2021-2025 | Farxiga, Airsupra |
| Sanofi Pasteur INC. | $60.27 | 2022-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $46.78 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.16 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $30.31 | 2021 | |
| Glaxosmithkline, LLC. | $29.45 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $28.99 | 2022 | |
| Janssen Pharmaceuticals, INC | $27.77 | 2022 | |
| Amgen INC. | $25.72 | 2023 | Repatha, Otezla |
| Hologic Sales and Service, LLC | $24.60 | 2025 | Thinprep 2000 Processor, Aptima |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $23.26 | 2023 | |
| Shield Therapeutics INC | $19.00 | 2024 | |
| Cranial Technologies, INC | $17.83 | 2025 | Doc Band |
| Novartis Pharmaceuticals Corporation | $14.26 | 2022 | |
| Phadia US INC. | $13.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Cuevas Loya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.